“Two-phase”的搜索结果，显示 281-290 项，共有 4289 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

2. Bispecific antibody therapy - 妙佑医疗国际

   Faricimab (Vabysmo) blocks VEGF and Ang-2, two ... Time away from home. You may need to remain close to the treatment facility for the first phase of treatment.

3. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   ... stage glioma tumors and evaluate response to therapy. ... This randomized phase III trial compares ... Go to page 22 · Go to page 33 · Go to page 44 · Next ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of ... 2 prior lines of therapy. The primary objectives are to determine the ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

6. 乳腺癌- 医生与科室- 妙佑医疗国际

   ... Stage 4 breast cancer, BRCA gene mutation ... Stage 4 breast cancer, BRCA gene ... Castro Garcia, M.D.. Pagination 医生搜索. Go to page 11 · Go to page 22 ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of ... 2 prior lines of therapy. The primary objectives are to determine the ...

8. 急性肾损伤- 医生与科室- 妙佑医疗国际

   Nephrologist. Jacksonville, FL. 擅长领域：. Point of care ultrasound, High blood pressure, Kidney stone, Chronic kidney disease, End-stage renal disease, ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of ... 2 prior lines of therapy. The primary objectives are to determine the ...